Shares in Bruker BioSciences briefly climbed to a 52-week high of $5.70 this week, before closing up 11.75 percent to $5.61 on Tuesday. The firm's shares rose this past week after announcing a biodefense contract for the United Arab Emirates. Molecular Devices also hovered near a 52-week high, closing up 8.89 percent for the tracking period ended Tuesday.

Harvard Bioscience led decliners for the week, closing the period down 7.39 percent.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.